STAA241018P32500
- 0.65
- +0.24+58.54%
Staar Surgical Newsroom
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $44
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA) and Repligen (RGEN)
Staar Surgical Price Target Cut to $44.00/Share From $50.00 by Stifel
Staar Surgical Analyst Ratings
Stifel Maintains Buy on Staar Surgical, Lowers Price Target to $44
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $44
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $41
Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Staar Surgical (STAA) and Organon (OGN)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), Cadrenal Therapeutics, Inc. (CVKD) and Allogene Therapeutics (ALLO)
Staar Surgical Hold Rating: Solid Performance Amid Global Economic Uncertainty and China Market Concerns
Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $41
Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Staar Surgical (STAA) and Pliant Therapeutics (PLRX)
Staar Surgical Analyst Ratings
Staar Surgical (STAA) Gets a Hold From Needham
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $50
Stifel Nicolaus Sticks to Their Buy Rating for Staar Surgical (STAA)
Morgan Stanley Cuts STAAR to Underweight, Cites Growth Expectations
BTIG Maintains Buy on Staar Surgical, Raises Price Target to $53